Wave Life Sciences Financial Overview
Wave Life Sciences's market cap is currently $3.25B. The company's EPS TTM is $-0.32; its P/E ratio is -23.78; Wave Life Sciences is scheduled to report earnings on November 10, 2025, and the estimated EPS forecast is $-0.27. See an overview of income statement, balance sheet, and cash flow financials.
